Macromolecule

Global Merchant API Market to Reach $90.97 Billion by 2023, Fueled by Rising Diabetes Incidence and Growing Outsourcing Trend - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 9, 2023

The global merchant API market is on track to achieve a market value of US$90.97 billion by 2023, with a notable Compound Annual Growth Rate (CAGR) of 6.97% over the forecast period.

Key Points: 
  • The global merchant API market is on track to achieve a market value of US$90.97 billion by 2023, with a notable Compound Annual Growth Rate (CAGR) of 6.97% over the forecast period.
  • Pharmaceutical companies are increasingly outsourcing manufacturing to focus on core competencies like research and development (R&D) and marketing, contributing to the growth of the merchant API market.
  • The global merchant API market is segmented as follows:
    Molecular Type: This segment is divided into Small Molecules and Large Molecules.
  • Small molecules currently hold the largest market share due to the growing demand for small-molecule drugs and the outsourcing trend.

Einstein-Developed Treatment Strategy May Lead to HIV Cure

Retrieved on: 
Thursday, October 21, 2021

"Although ART works remarkably well at keeping HIV in check indefinitely, it is a stalemate and not a checkmate," said co-corresponding author Harris Goldstein, M.D.

Key Points: 
  • "Although ART works remarkably well at keeping HIV in check indefinitely, it is a stalemate and not a checkmate," said co-corresponding author Harris Goldstein, M.D.
  • "It's unlikely that any treatment strategy can remove all latently infected T cells," said Dr. Goldstein.
  • "Our goal with synTac is a 'functional cure,' in which the powerful immune response induced by synTac suppresses HIV to undetectable levels even after they discontinue ART."
  • Next, the researchers intravenously injected synTacs specific for HIV or CMV into virus-infected mice with "humanized" immune systems that permit infection by viruses affecting people, such as HIV and CMV.